A research team in the US has devised a new genome analysis approach that can identify large proportions of people who are at a higher risk of developing serious common diseases such as coronary artery disease.
The research has been carried out by the Broad Institute of MIT and Harvard in partnership with Massachusetts General Hospital (MGH) and Harvard Medical School.
According to the researchers, this polygenic risk scoring can predict greater chances of developing potentially fatal disorders well before the appearance of symptoms.
